|

IAM1363 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Iambic Therapeutics, Inc1

Indications

  • HER2-positive Gastroesophageal Cancer1
  • HER2 + Gastric Cancer1
  • HER2-positive Colorectal Cancer1
  • HER2-positive Bladder Cancer1
  • HER2-Positive Solid Tumors1

La Jolla, California1 trial

A Phase 1/1b Study of IAM1363 in HER2 Cancers

UCSD Moores Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.